Abstract
Background Ethiopia is a priority country of Gavi, the Vaccine Alliance to improve vaccination coverage and equitable uptake. The Ethiopian National Expanded Programme on Immunisation (EPI) and the Global Vaccine Action Plan set coverage goals of 90% at national level and 80% at district level by 2020. This study aims to analyse basic vaccination coverage among children in Ethiopia and to estimate the equity impact by socioeconomic, geographic, maternal and child characteristics based on data from the Ethiopia Demographic and Health Survey 2016.
Methods Basic vaccination coverage (1-dose BCG, 3-doses DPT-HepB-Hib, 3-doses polio, 1-dose measles vaccine) of 2,004 children aged 12-23 months was analysed. Mean coverage was disaggregated by socioeconomic (household wealth, religion, ethnicity), geographic (area of residence, region), maternal (maternal age at birth, maternal education, maternal marital status, sex of household head) and child (sex of child, birth order) characteristics. Concentration indices assessed wealth and education-related inequalities. Multiple logistic regression estimated associations between basic vaccination coverage and socioeconomic, maternal and child characteristics.
Results National coverage for basic vaccinations was 39.7% in 2016. Single vaccination coverage ranged between between 53.2% (DTP3) and 69.2% (BCG). Wealth and maternal education related inequities were present for all vaccines. Children from richer households, urban regions, primary maternal education and male headed households were associated with higher vaccination coverage. The Ethiopia Mini Demographic and Health Survey 2019 reports national coverage for basic vaccinations at 43.3% with single vaccination coverage ranging between 57.8% (measles) and 74.2% (BCG).
Conclusions Vaccination coverage has improved from 2016 to 2019, but remains below the coverage goals of the EPI. Low vaccination coverage is associated with poorer households, rural regions of Afar and Somali, no maternal education and female headed households. Targeted approaches are necessary to improve vaccination coverage among these population subgroups and equitable uptake of vaccines in Ethiopia.
Competing Interest Statement
The authors have declared no competing interest.
Clinical Trial
not applicable
Funding Statement
Anne Geweniger received no external funding. Kaja M. Abbas is supported by NIH/NIGMS R01GM109718 and the Vaccine Impact Modelling Consortium (OPP1157270).
Author Declarations
All relevant ethical guidelines have been followed; any necessary IRB and/or ethics committee approvals have been obtained and details of the IRB/oversight body are included in the manuscript.
Yes
All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.
Yes
Data Availability
The 2016 Ethiopia DHS data file (ETKR71DT.ZIP) used in this study is accessible on the DHS website (https://dhsprogram.com/data/dataset/Ethiopia_Standard-DHS_2016.cfm) and available to registered users
https://dhsprogram.com/data/dataset/Ethiopia_Standard-DHS_2016.cfm
